Jenscare Scientific Future Growth
Future criteria checks 2/6
Jenscare Scientific is forecast to grow revenue at 105.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 34.4% |
Revenue growth rate | 105.1% |
Future return on equity | -1.2% |
Analyst coverage | Low |
Last updated | 07 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 484 | N/A | N/A | 264 | 1 |
12/31/2024 | 206 | N/A | N/A | 11 | 1 |
12/31/2023 | N/A | -372 | -301 | -222 | N/A |
9/30/2023 | N/A | -457 | -273 | -207 | N/A |
6/30/2023 | N/A | -542 | -246 | -191 | N/A |
3/31/2023 | N/A | -491 | -214 | -175 | N/A |
12/31/2022 | N/A | -439 | -182 | -158 | N/A |
9/30/2022 | N/A | -322 | -175 | -153 | N/A |
6/30/2022 | N/A | -205 | -168 | -148 | N/A |
3/31/2022 | N/A | -353 | -163 | -145 | N/A |
12/31/2021 | N/A | -501 | -157 | -142 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 9877's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 9877's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 9877's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 9877's revenue (105.1% per year) is forecast to grow faster than the Hong Kong market (7.4% per year).
High Growth Revenue: 9877's revenue (105.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9877 is forecast to be unprofitable in 3 years.